Abstract
Introduction
Neuroendocrine tumors have malignant potential, and lymph node metastasis can occur. This study aimed to identify predictive factors of lymph node metastasis and prognostic factors for survival in rectal neuroendocrine tumors.
Methods
Sixty-four patients underwent endoscopic or surgical treatment for rectal NET. The data on these patients were collected in our database prospectively and reviewed retrospectively.
Results
Transanal excision was performed in 28 (43.8%) patients, endoscopic mucosal resection or submucosal dissection was performed in 15 (23.4%) patients, and radical resection was performed in 21 (31.8%) patients. Lymph node and distant metastasis was present in 16 (25.0%) and fir (7.8%) patients. The significant risk factors for lymph node metastasis identified in the multivariable analyses were tumor size (≥ 2 cm, p = 0.003) and tumor grade (G2, p < 0.001; G3, p = 0.008). In patients with a tumor smaller than 2 cm, the risk factors for lymph node metastasis included the tumor grade, mitosis count, and Ki-67 index. The median follow-up period was 30.0 months, and recurrence developed in four (6.8%) patients. The significant prognostic factors for survival included tumor size, T stage, lymph node metastasis, and tumor grade.
Conclusion
Tumor grade combined with tumor size is an important predictive factor for lymph node metastasis and could serve as a prognostic factor for survival outcomes.
Similar content being viewed by others
References
Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas 2010;39:707–712. https://doi.org/10.1097/MPA.0b013e3181ec124e.
Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 2004;1014:13–27.
Cheek RC, Wilson H. Carcinoid tumors. Curr Probl Surg 1970 4–31.
Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am 2011;40:1–18. https://doi.org/10.1016/j.ecl.2010.12.005.
Cho MY, Kim JM, Sohn JH, Kim MJ, Kim KM, Kim WH, Kim H, Kook MC, Park do Y, Lee JH, Chang H, Jung ES, Kim HK, Jin SY, Choi JH, Gu MJ, Kim S, Kang MS, Cho CH, Park MI, Kang YK, Kim YW, Yoon SO, Bae HI, Joo M, Moon WS, Kang DY, Chang SJ. Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000-2009: multicenter study. Cancer Res Treat 2012;44:157–165. https://doi.org/10.4143/crt.2012.44.3.157.
Mandair D, Caplin ME. Colonic and Rectal NET's. Best Pract Res Clin Gastroenterol 2012;26:775–789. https://doi.org/10.1016/j.bpg.2013.01.007.
Colonoscopy Study Group of Korean Society of Coloproctology. Clinical characteristics of colorectal carcinoid tumors. J Korean Soc Coloproctol 2011;27:17–20. https://doi.org/10.3393/jksc.2011.27.1.17.
Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology 2005;128:1717–1751.
Ramage J, De Herder WW, Delle Fave GF, Ferolla P, Ferone D, Ito T, Ruszniewski P, Sundin A, Weber W, Zheng-Pei Z, Taal B, Pascher A. Consensus guidelines update for colorectal neuroendocrine neoplasms (NEN). Neuroendocrinology 2016;103:139–143. https://doi.org/10.1159/000443166.
Moon SH, Hwang JH, Sohn DK, Park JW, Hong CW, Han KS, Chang HJ, Oh JH. Endoscopic submucosal dissection for rectal neuroendocrine (carcinoid) tumors. J Laparoendosc Adv Surg Tech A 2011;21:695–699. https://doi.org/10.1089/lap.2011.0068.
Son HJ, Sohn DK, Hong CW, Han KS, Kim BC, Park JW, Choi HS, Chang HJ, Oh JH. Factors associated with complete local excision of small rectal carcinoid tumor. Int J Colorectal Dis 2013;28:57–61. https://doi.org/10.1007/s00384-012-1538-z.
Anthony LB, Strosberg JR, Klimstra DS, Maples WJ, O'Dorisio TM, Warner RR, Wiseman GA, Benson AB, 3rd, Pommier RF, North American Neuroendocrine Tumor S. The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum. Pancreas 2010;39:767–774. https://doi.org/10.1097/MPA.0b013e3181ec1261.
Klimstra DS. Pathology reporting of neuroendocrine tumors: essential elements for accurate diagnosis, classification, and staging. Semin Oncol 2013;40:23–36. https://doi.org/10.1053/j.seminoncol.2012.11.001.
Yamaguchi T, Fujimori T, Tomita S, Ichikawa K, Mitomi H, Ohno K, Shida Y, Kato H. Clinical validation of the gastrointestinal NET grading system: Ki67 index criteria of the WHO 2010 classification is appropriate to predict metastasis or recurrence. Diagn Pathol 2013;8:65. https://doi.org/10.1186/1746-1596-8-65.
Hotta K, Shimoda T, Nakanishi Y, Saito D. Usefulness of Ki-67 for predicting the metastatic potential of rectal carcinoids. Pathol Int 2006;56:591–596. https://doi.org/10.1111/j.1440-1827.2006.02013.x.
Yamagishi D, Matsubara N, Noda M, Yamano T, Tsukamoto K, Kuno T, Hamanaka M, Kobayashi M, Ikeuchi H, Matsuda I, Hirota S, Tomita N. Clinicopathological characteristics of rectal carcinoid patients undergoing surgical resection. Oncol Lett 2012;4:910–914. https://doi.org/10.3892/ol.2012.868.
Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR. AJCC Cancer Staging Manual, 8th ed. New York: Springer, 2017.
Bosman F, Carneiro F, Hruban R, Theise N. WHO Classification of Tumours of the Digestive System, 4th ed. Lyon: IARC Press, 2010.
Brown G, Richards CJ, Bourne MW, Newcombe RG, Radcliffe AG, Dallimore NS, Williams GT. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 2003;227:371–377. https://doi.org/10.1148/radiol.2272011747.
Chagpar R, Chiang YJ, Xing Y, Cormier JN, Feig BW, Rashid A, Chang GJ, You YN. Neuroendocrine tumors of the colon and rectum: prognostic relevance and comparative performance of current staging systems. Ann Surg Oncol 2013;20:1170–1178. https://doi.org/10.1245/s10434-012-2746-z.
Lee JL, Yu CS, Kim M, Hong SM, Lim SB, Kim JC. Prognostic impact of diagnosing colorectal neuroendocrine carcinoma using the World Health Organization 2010 classification. Surgery 2014;155:650–658. https://doi.org/10.1016/j.surg.2013.11.012.
Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934–959. https://doi.org/10.1002/cncr.11105.
Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 2010;28:264–271. https://doi.org/10.1200/JCO.2009.24.0952.
Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart A. Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J Clin Oncol 2010;28:256–263. https://doi.org/10.1200/JCO.2009.23.9194.
Rindi G, Kloppel G, Couvelard A, Komminoth P, Korner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2007;451:757–762. https://doi.org/10.1007/s00428-007-0452-1.
Strosberg JR, Weber JM, Feldman M, Coppola D, Meredith K, Kvols LK. Prognostic validity of the American joint committee on cancer staging classification for midgut neuroendocrine tumors. J Clin Oncol 2013;31:420–425. https://doi.org/10.1200/JCO.2012.44.5924.
Bryant CL, Lunniss PJ, Knowles CH, Thaha MA, Chan CL. Anterior resection syndrome. Lancet Oncol 2012;13:e403-e408. https://doi.org/10.1016/S1470-2045(12)70236-X.
Pucciani F. A review on functional results of sphincter-saving surgery for rectal cancer: the anterior resection syndrome. Updates Surg 2013;65:257–263. https://doi.org/10.1007/s13304-013-0220-5.
Emmertsen KJ, Laurberg S. Bowel dysfunction after treatment for rectal cancer. Acta Oncol 2008;47:994–1003. https://doi.org/10.1080/02841860802195251.
Wang AY, Ahmad NA. Rectal carcinoids. Curr Opin Gastroenterol 2006;22:529–535. https://doi.org/10.1097/01.mog.0000239868.27328.1d.
Jetmore AB, Ray JE, Gathright JB, Jr., McMullen KM, Hicks TC, Timmcke AE. Rectal carcinoids: the most frequent carcinoid tumor. Dis Colon rectum 1992;35:717–725.
Shields CJ, Tiret E, Winter DC, International Rectal Carcinoid Study Group. Carcinoid tumors of the rectum: a multi-institutional international collaboration. Ann Surg 2010;252:750–755. https://doi.org/10.1097/SLA.0b013e3181fb8df6.
Sullivan TC. Anorectal carcinoid tumors: is aggressive surgery warranted? Ann Surg 1990;212:650–651.
Park CH, Cheon JH, Kim JO, Shin JE, Jang BI, Shin SJ, Jeen YT, Lee SH, Ji JS, Han DS, Jung SA, Park DI, Baek IH, Kim SH, Chang DK. Criteria for decision making after endoscopic resection of well-differentiated rectal carcinoids with regard to potential lymphatic spread. Endoscopy 2011;43:790–795. https://doi.org/10.1055/s-0030-1256414.
Soga J. Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. Cancer 2005;103:1587–1595. https://doi.org/10.1002/cncr.20939.
Lee SH, Kim BC, Chang HJ, Sohn DK, Han KS, Hong CW, Lee EJ, Lee JB, Lee DS, Lee IT, Youk EG. Rectal neuroendocrine and L-cell tumors: diagnostic dilemma and therapeutic strategy. Am J Surg Pathol 2013;37:1044–1052. https://doi.org/10.1097/PAS.0b013e3182819f0f.
Khan MS, Luong TV, Watkins J, Toumpanakis C, Caplin ME, Meyer T. A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms. Br J Cancer 2013;108:1838–1845. https://doi.org/10.1038/bjc.2013.156.
Sugimoto S, Hotta K, Shimoda T, Imai K, Yamaguchi Y, Nakajima T, Oishi T, Mori K, Takizawa K, Kakushima N, Tanaka M, Kawata N, Matsubayashi H, Ono H. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors. Surg Endosc 2016;30:4239–4248. https://doi.org/10.1007/s00464-015-4735-3.
Salama A, Badawy O, Mokhtar N. Ki-67 is a powerful tool for grading neuroendocrine tumors among Egyptian Patients: a 10-year experience. J Cancer Res Clin Oncol 2014;140:653–661. https://doi.org/10.1007/s00432-014-1603-9.
Fahy BN, Tang LH, Klimstra D, Wong WD, Guillem JG, Paty PB, Temple LK, Shia J, Weiser MR. Carcinoid of the Rectum Risk Stratification (CaRRs): a strategy for preoperative outcome assessment. Ann Surg Oncol 2007;14:1735–1743. https://doi.org/10.1245/s10434-006-9311-6.
Muller S, Chesner IM, Egan MJ, Rowlands DC, Collard MJ, Swarbrick ET, Newman J. Significance of venous and lymphatic invasion in malignant polyps of the colon and rectum. Gut 1989;30:1385–1391.
Suh JH, Han KS, Kim BC, Hong CW, Sohn DK, Chang HJ, Kim MJ, Park SC, Park JW, Choi HS, Oh JH. Predictors for lymph node metastasis in T1 colorectal cancer. Endoscopy 2012;44:590–595. https://doi.org/10.1055/s-0031-1291665.
Harris EI, Lewin DN, Wang HL, Lauwers GY, Srivastava A, Shyr Y, Shakhtour B, Revetta F, Washington MK. Lymphovascular invasion in colorectal cancer: an interobserver variability study. Am J Surg Pathol 2008;32:1816–1821. https://doi.org/10.1097/PAS.0b013e3181816083.
Baumann T, Rottenburger C, Nicolas G, Wild D. Gastroenteropancreatic Neuroendocrine Tumours (GEP-NET): imaging and staging. Best Pract Res Clin Endocrinol Metab 2016;30:45–57. https://doi.org/10.1016/j.beem.2016.01.003.
Acknowledgements
Beonghoon Sohn and Yoomin Kwon contributed equally. The authors thank the members of the Medical Research Collaborating Center (MRCC) at Seoul National University Hospital for assistance with the statistical analysis.
Authorship
Sohn B, Kwon Y, and Ryoo SB designed the study and drafted the manuscript; B Sohn, Kwon Y, Ryoo SB, Song I, Kwon YH, Lee DW, Moon SH, Park JW, Jeong SY, and Park KJ conducted the research; Sohn B, Kwon Y, and Ryoo SB collected and analyzed the data; and B Sohn, Kwon Y, Ryoo SB, Song I, Kwon YH, Lee DW, Moon SH, Park JW, Jeong SY, and Park KJ reviewed and modified the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Sohn, B., Kwon, Y., Ryoo, SB. et al. Predictive Factors for Lymph Node Metastasis and Prognostic Factors for Survival in Rectal Neuroendocrine Tumors. J Gastrointest Surg 21, 2066–2074 (2017). https://doi.org/10.1007/s11605-017-3603-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-017-3603-y